BEXLAMDA Trademark

Trademark Overview

On Wednesday, September 4, 2013, a trademark application was filed for BEXLAMDA with the United States Patent and Trademark Office. The USPTO has given the BEXLAMDA trademark a serial number of 86055416. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2017. This trademark is owned by Bristol-Myers Squibb Company. The BEXLAMDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
bexlamda

General Information

Serial Number86055416
Word MarkBEXLAMDA
Filing DateWednesday, September 4, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, July 17, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 17, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 7, 2017EXTENSION 5 GRANTED
Monday, December 12, 2016EXTENSION 5 FILED
Monday, December 12, 2016TEAS EXTENSION RECEIVED
Thursday, July 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 20, 2016EXTENSION 4 GRANTED
Friday, June 10, 2016EXTENSION 4 FILED
Friday, June 10, 2016TEAS EXTENSION RECEIVED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 30, 2016EXTENSION 3 GRANTED
Thursday, December 10, 2015EXTENSION 3 FILED
Thursday, January 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 10, 2015TEAS EXTENSION RECEIVED
Saturday, July 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 10, 2015EXTENSION 2 GRANTED
Wednesday, June 10, 2015EXTENSION 2 FILED
Friday, July 10, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 10, 2015TEAS EXTENSION RECEIVED
Saturday, December 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 10, 2014EXTENSION 1 GRANTED
Wednesday, December 10, 2014EXTENSION 1 FILED
Wednesday, December 10, 2014TEAS EXTENSION RECEIVED
Tuesday, June 10, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 15, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 15, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 13, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 10, 2014ASSIGNED TO LIE
Saturday, February 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 21, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 21, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 21, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 17, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, December 17, 2013PRIORITY ACTION E-MAILED
Tuesday, December 17, 2013PRIORITY ACTION WRITTEN
Tuesday, December 10, 2013ASSIGNED TO EXAMINER
Thursday, September 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 7, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

bexlamda diseases pharmaceutical human anti preparations disorders organ solid auto immune